Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 826 to 850 of about 6093

Previous 25

Website Changes

10/20/2021

PLUS THERAPEUTICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR 186RNL FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES

10/16/2021

Systemic coagulation is activated in patients with meningioma and glioblastoma

10/07/2021

ONC206 for Treatment of Newly Diagnosed, or Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant Brain Tumors (PNOC 023)

10/04/2021

Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial

10/04/2021

Sharing your GBM Experience Helps Others

09/30/2021

Oblato Announces that it has received a Positive Response from the FDA for the use of OKN-007 for patients with high-grade gliomas in an Expanded Access Program

09/28/2021

Neuroscientist Michelle Monje awarded MacArthur `genius grant`

09/26/2021

Musella Foundation awards $50,000 brain tumor research grant!

09/25/2021

xINFORM - Personalized Treatment Options Software

09/25/2021

Sunday`s 9/26/21 webinar is postponed!

09/23/2021

Novel Virus Targeting Deadly Brain Tumors Shows Early Promise

09/21/2021

The Musella Foundation presents two webinars this week!

09/12/2021

Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial

09/11/2021

The Importance of Shared Decision-Making for Patients with Glioblastoma

09/11/2021

A Month I Hope No Reader Must Face the Loss of A Child

09/07/2021

Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 2 newly diagnosed disease

09/05/2021

Does proton therapy have a role in the treatment of brain tumors?

08/28/2021

#CancelChildhoodCancer citizen petition campaign.

08/26/2021

Researchers Discover Treatment That May Be Viable For Human Brain Cancer

08/25/2021

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3

08/25/2021

Help Us Better Understand Glioblastoma Multiforme

08/25/2021

Musella Foundation Copay Program now closed to new and renewal patients

08/12/2021

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3

08/12/2021

Hackensack Meridian Children’s Health Children’s Cancer Institute Now a Member of the Pacific Pediatric Neuro-Oncology Consortium (PNOC)

08/11/2021

Musella Foundation Copay Assistance program is running low on funding

Our Terms of Use and Privacy Policy has changed.
Click HERE to read it!